Methocarbamol
- Product NDC
- 68071-2513
- 11-digit product format
- 680712513
- Labeler code
- 68071
- Product ID
- 68071-2513_ca505dbe-1211-619b-e053-2a95a90a62ed
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methocarbamol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA040489
- Marketing category
- ANDA
- Marketing start
- 2019-08-15
- Marketing end
- 0000-00-00
- Substance
- METHOCARBAMOL
- Active strength
- 750 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-2513-2 | Methocarbamol | 20 in 1 BOTTLE | TABLET | 20 | | 1 |
| 68071-2513-3 | Methocarbamol | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-2513 | METHOCARBAMOL TABLET [NUCARE PHARMACEUTICALS,INC.] | 1 | Legacy NDC, 1 package rows | 20210825_ca5153da-e921-0bc4-e053-2995a90ac6aa.zip |
| 68071-2513 | METHOCARBAMOL TABLET [NUCARE PHARMACEUTICALS,INC.] | 1 | Legacy NDC, 1 package rows | 20210825_ca5060d8-4d38-7c19-e053-2995a90a3bdb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2513-2 | 68071251302 | 20 TABLET in 1 BOTTLE (68071-2513-2) | 20 tablet | 2021-08-24 | 0000-00-00 | No | No | Current |
| 68071-2513-3 | 68071251303 | 30 TABLET in 1 BOTTLE (68071-2513-3) | 30 tablet | 2021-08-24 | 0000-00-00 | No | No | Current |